Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease

Abstract Background Autosplenectomy, as a result of sickle cell disease, is an important risk factor for severe malaria. While molecular methods are helpful in providing rapid and accurate infection detection and species identification, the effect of hyposplenism on result interpretation during the...

Full description

Bibliographic Details
Main Authors: Paul M. Luethy, Sean C. Murphy, Annette M. Seilie, Yingda L. Xie, Chuen-Yen Lau, John F. Tisdale, Matthew M. Hsieh, Jessica L. Reinhardt, Anna F. Lau, Gary A. Fahle
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Malaria Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12936-017-2152-x
_version_ 1811259382081519616
author Paul M. Luethy
Sean C. Murphy
Annette M. Seilie
Yingda L. Xie
Chuen-Yen Lau
John F. Tisdale
Matthew M. Hsieh
Jessica L. Reinhardt
Anna F. Lau
Gary A. Fahle
author_facet Paul M. Luethy
Sean C. Murphy
Annette M. Seilie
Yingda L. Xie
Chuen-Yen Lau
John F. Tisdale
Matthew M. Hsieh
Jessica L. Reinhardt
Anna F. Lau
Gary A. Fahle
author_sort Paul M. Luethy
collection DOAJ
description Abstract Background Autosplenectomy, as a result of sickle cell disease, is an important risk factor for severe malaria. While molecular methods are helpful in providing rapid and accurate infection detection and species identification, the effect of hyposplenism on result interpretation during the course of infection should be carefully considered. Case presentation A 32-year old autosplenectomized Nigerian male with severe sickle cell disease was referred to the National Institutes of Health for allogenic hematopoietic stem cell transplant. Despite testing negative for malaria by both smear and PCR 2 weeks after arrival in the USA, the patient developed fever and diffuse bilateral lower rib cage and upper abdominal pain 2 weeks later and subsequently tested positive for Plasmodium falciparum. Parasitaemia was tracked over time by microscopy and nucleic acid tests to evaluate the therapeutic response in the setting of hyposplenism. The patient showed prompt resolution of patent infection by microscopy but remained positive by molecular methods for > 30 days after treatment initiation. Conclusion While molecular testing can provide sensitive Plasmodium nucleic acid detection, the persistence of Plasmodium nucleic acids following adequate treatment in functionally asplenic patients can lead to a diagnostic dilemma. In such patients, clinical response and peripheral blood smears should guide patient management following treatment. Nonetheless, in pre-transplant patients at high-risk for pre-existing Plasmodium infections, highly sensitive molecular assays can be useful to rule out infection prior to transplantation.
first_indexed 2024-04-12T18:30:31Z
format Article
id doaj.art-c337a5a445c34c41b636e16d1da824ce
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-04-12T18:30:31Z
publishDate 2018-01-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-c337a5a445c34c41b636e16d1da824ce2022-12-22T03:21:06ZengBMCMalaria Journal1475-28752018-01-011711510.1186/s12936-017-2152-xDiagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell diseasePaul M. Luethy0Sean C. Murphy1Annette M. Seilie2Yingda L. Xie3Chuen-Yen Lau4John F. Tisdale5Matthew M. Hsieh6Jessica L. Reinhardt7Anna F. Lau8Gary A. Fahle9Microbiology Service, Department of Laboratory Medicine, National Institutes of HealthDepartment of Laboratory Medicine, University of WashingtonDepartment of Laboratory Medicine, University of WashingtonNational Institute of Allergy and Infectious Diseases, National Institutes of HealthNational Institute of Allergy and Infectious Diseases, National Institutes of HealthMolecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of HealthMolecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of HealthMicrobiology Service, Department of Laboratory Medicine, National Institutes of HealthMicrobiology Service, Department of Laboratory Medicine, National Institutes of HealthMicrobiology Service, Department of Laboratory Medicine, National Institutes of HealthAbstract Background Autosplenectomy, as a result of sickle cell disease, is an important risk factor for severe malaria. While molecular methods are helpful in providing rapid and accurate infection detection and species identification, the effect of hyposplenism on result interpretation during the course of infection should be carefully considered. Case presentation A 32-year old autosplenectomized Nigerian male with severe sickle cell disease was referred to the National Institutes of Health for allogenic hematopoietic stem cell transplant. Despite testing negative for malaria by both smear and PCR 2 weeks after arrival in the USA, the patient developed fever and diffuse bilateral lower rib cage and upper abdominal pain 2 weeks later and subsequently tested positive for Plasmodium falciparum. Parasitaemia was tracked over time by microscopy and nucleic acid tests to evaluate the therapeutic response in the setting of hyposplenism. The patient showed prompt resolution of patent infection by microscopy but remained positive by molecular methods for > 30 days after treatment initiation. Conclusion While molecular testing can provide sensitive Plasmodium nucleic acid detection, the persistence of Plasmodium nucleic acids following adequate treatment in functionally asplenic patients can lead to a diagnostic dilemma. In such patients, clinical response and peripheral blood smears should guide patient management following treatment. Nonetheless, in pre-transplant patients at high-risk for pre-existing Plasmodium infections, highly sensitive molecular assays can be useful to rule out infection prior to transplantation.http://link.springer.com/article/10.1186/s12936-017-2152-xPlasmodium falciparumSickle cell diseaseAutosplenectomyPCRRT-PCR18S rRNA
spellingShingle Paul M. Luethy
Sean C. Murphy
Annette M. Seilie
Yingda L. Xie
Chuen-Yen Lau
John F. Tisdale
Matthew M. Hsieh
Jessica L. Reinhardt
Anna F. Lau
Gary A. Fahle
Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease
Malaria Journal
Plasmodium falciparum
Sickle cell disease
Autosplenectomy
PCR
RT-PCR
18S rRNA
title Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease
title_full Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease
title_fullStr Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease
title_full_unstemmed Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease
title_short Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease
title_sort diagnostic challenges of prolonged post treatment clearance of plasmodium nucleic acids in a pre transplant autosplenectomized patient with sickle cell disease
topic Plasmodium falciparum
Sickle cell disease
Autosplenectomy
PCR
RT-PCR
18S rRNA
url http://link.springer.com/article/10.1186/s12936-017-2152-x
work_keys_str_mv AT paulmluethy diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease
AT seancmurphy diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease
AT annettemseilie diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease
AT yingdalxie diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease
AT chuenyenlau diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease
AT johnftisdale diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease
AT matthewmhsieh diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease
AT jessicalreinhardt diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease
AT annaflau diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease
AT garyafahle diagnosticchallengesofprolongedposttreatmentclearanceofplasmodiumnucleicacidsinapretransplantautosplenectomizedpatientwithsicklecelldisease